You have read all your free articles, to continue reading subscribe to read the rest of this content.
Stockholm-based BioLamina recently signed a new R&D agreement with Roche to develop novel cell culture systems. The systems will be aimed at various applications, including stem cell research. BioLamina’s and Roche’s collaboration will focus on assessing laminin-based in-vitro cell culturAlready a subscriber Login You have read all your free articles,…
The Board of Directors of BioInvent International has resolved to issue a directed share issue to Swedish and international institutional investors. Investors in the Directed Share Issue are a number of Swedish and international investors, including new investors such as HBM Healthcare InvestmentAlready a subscriber Login You have read all…
Tarek Samad will join Lundbeck on 1 May 2021 as Senior Vice President, Head of Research. Samad will play a key role in Lundbeck’s ambition to have a premier neuroscience pipeline and to continue the transformation towards a focus on helping people living with niche and rare brain diseases, the…
The company has entered an agreement with the United States Department of Defense (DoD) for the development of a prophylactic vaccine against the equine encephalitis virus-a rare, but potentially deadly mosquito-borne illness. With funding from the DoD, Bavarian Nordic will utilize its MVA-BN plaAlready a subscriber Login You have read…
